AXSM logo

AXSM
Axsome Therapeutics Inc

11,715
Mkt Cap
$7.53B
Volume
169.00
52W High
$149.77
52W Low
$75.56
PE Ratio
-31.98
AXSM Fundamentals
Price
$149.44
Prev Close
$143.31
Open
$143.90
50D MA
$128.53
Beta
0.71
Avg. Volume
462,663.09
EPS (Annual)
-$5.99
P/B
101.97
Rev/Employee
$564,704.25
Loading...
Loading...
News
all
press releases
Magnetar Financial LLC Invests $2.12 Million in Axsome Therapeutics, Inc. $AXSM
Magnetar Financial LLC bought a new position in Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) during the second quarter, according to its most recent filing with the SEC. The firm bought...
MarketBeat·2h ago
News Placeholder
More News
News Placeholder
Cornerstone Select Advisors LLC Takes $457,000 Position in Axsome Therapeutics, Inc. $AXSM
Cornerstone Select Advisors LLC purchased a new position in Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing...
MarketBeat·4h ago
News Placeholder
Cynosure Group LLC Raises Stake in Axsome Therapeutics, Inc. $AXSM
Cynosure Group LLC boosted its position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 45.1% in the 2nd quarter, according to its most recent filing with the Securities...
MarketBeat·4h ago
News Placeholder
Axsome Therapeutics, Inc. $AXSM Shares Purchased by DNB Asset Management AS
DNB Asset Management AS lifted its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 24.6% in the 2nd quarter, according to its most recent filing with the Securities & Exchange...
MarketBeat·4h ago
News Placeholder
Axsome Therapeutics, Inc. $AXSM Shares Purchased by Los Angeles Capital Management LLC
Los Angeles Capital Management LLC boosted its holdings in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 154.5% during the 2nd quarter, according to its most recent 13F filing...
MarketBeat·8d ago
News Placeholder
Candriam S.C.A. Trims Holdings in Axsome Therapeutics, Inc. $AXSM
Candriam S.C.A. trimmed its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 4.0% during the second quarter, according to the company in its most recent 13F filing with the...
MarketBeat·8d ago
News Placeholder
Campbell & CO Investment Adviser LLC Purchases New Holdings in Axsome Therapeutics, Inc. $AXSM
Campbell & CO Investment Adviser LLC acquired a new stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) in the second quarter, according to the company in its most recent 13F...
MarketBeat·10d ago
News Placeholder
Axsome Therapeutics (NASDAQ:AXSM) Hits New 12-Month High - What's Next?
Axsome Therapeutics (NASDAQ:AXSM) Sets New 52-Week High - Time to Buy...
MarketBeat·11d ago
News Placeholder
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Given Average Rating of "Moderate Buy" by Brokerages
Axsome Therapeutics, Inc. (NASDAQ:AXSM - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the eighteen brokerages that are currently covering the company, Marketbeat...
MarketBeat·13d ago
News Placeholder
Equities Analysts Offer Predictions for AXSM FY2025 Earnings
Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) - Research analysts at William Blair boosted their FY2025 earnings per share estimates for shares of Axsome Therapeutics in a report released on...
MarketBeat·16d ago

Latest AXSM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.